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The immunoglobulin E (IgE)-mediated mast cell (MC)
response is central to the pathogenesis of type I
allergy and asthma. IkB kinase 2 (IKK2) was reported
to couple IgE-induced signals to MC degranulation
by phosphorylating the SNARE protein SNAP23.
We investigatedMC responses inmice with MC-spe-
cific inactivation of IKK2 or NF-kB essential modu-
lator (NEMO), or animals with MC-specific expres-
sion of a mutant, constitutively active IKK2. We
show that the IgE-induced late-phase cytokine
response is reduced in mice lacking IKK2 or NEMO
in MCs. However, anaphylactic in vivo responses of
these animals are not different from those of control
mice, and in vitro IKK2-deficient MCs readily phos-
phorylate SNAP23 and degranulate similarly to con-
trol cells in response to allergen or calcium iono-
phore. Constitutive overactivation of the NF-kB
pathway has only slight effects on allergen-triggered
MC responses. Thus, IKK2 is dispensable for MC
degranulation, and the important question how IgE-
induced signals trigger MC vesicle fusion remains
open.
INTRODUCTION
Mast cells (MCs) are themost important effector cells in immuno-
globulin E (IgE)-mediated allergic immune responses (Galli and
Tsai, 2012). IgE binds to the high-affinity receptor for IgE (FcεRI)
on MCs, and crosslinking of FcεRI-bound IgE by multivalent
antigen triggers immediate release of preformed proinflamma-
tory mediators stored in the prominent cytoplasmic granules,
including histamine and tumor necrosis factor (TNF). Several
hours after IgE-mediated exocytosis of secretory granules
(‘‘degranulation’’), theMC secretes a range of cytokines, chemo-
kines, and lipid mediators synthesized de novo in response to
the stimulus (‘‘late-phase response’’). Both phases of the MC1300 Cell Reports 8, 1300–1307, September 11, 2014 ª2014 The AuIgE response are key events in the pathogenesis of allergic dis-
ease (Galli and Tsai, 2012). Crosslinking of MC-bound IgE trig-
gers a signaling cascade (reviewed in Kambayashi and Koretzky,
2007) resulting in IP3- and DAG-triggered Ca
2+ mobilization and
activation of protein kinase (PK) C, which leads to degranulation
and induction of genes encoding proinflammatory mediators.
FcεRI-induced gene induction is controlled among others via
NF-kB transcription factors (Jeong et al., 2002; Klemm et al.,
2006; Lorentz et al., 2003; Peng et al., 2005). These dimeric fac-
tors are sequestered in the cytosol by inhibitor of NF-kB (IkB)
proteins in the steady state. NF-kB activity is controlled by the
IKK complex, which phosphorylates IkB proteins, targeting
them for proteasomal degradation thereby releasing NF-kB to
activate transcription. The IKK complex consists of two kinases,
IKK1 and IKK2, and the essential scaffolding protein NEMO.
Downstream of PKC activated by FcεRI-induced second
messenger signals, Bcl10 and Malt1 transduce a signal acti-
vating the IKK complex and thereby elicit NF-kB translocation
and MC late-phase cytokine production (Klemm et al., 2006).
In contrast to de novo mediator synthesis, FcεRI-induced MC
degranulation does not depend on NF-kB (Klemm et al., 2006;
Marquardt and Walker, 2000). Calcium sensors activated by
proximal FcεRI signaling activate the soluble N-ethylmalei-
mide-sensitive-factor attachment receptor (SNARE) protein ma-
chinery, which triggers fusion of secretory vesicles with the
plasma membrane (Lorentz et al., 2012). An important MC
SNARE protein is synaptosome-associated protein of 23 kDa
(SNAP23) (Lorentz et al., 2012). Although phosphorylation of
SNAP23 on residues 95 and 120 is essential for MC degranula-
tion (Hepp et al., 2005), little was known about events coupling
the second messenger signals to SNARE protein activation.
IKK2 was proposed to phosphorylate MC SNAP23 in response
to IgE signals in an NF-kB-independent fashion (Suzuki and
Verma, 2008). Given that complete loss of IKK2 causes embry-
onic lethality, this study relied on MCs differentiated from
Ikk2/ fetal liver cells (FLMCs). These cells featured a defect
in IgE-mediated SNAP23 phosphorylation and degranulation
in vitro. Moreover, anaphylactic responses of MC-deficient Kit
mutant mice were restored by reconstitution with wild-type but
not Ikk2/ FLMCs.thors
Figure 1. MC-Specific Inactivation of the
Ikk2 and theNemoGene, MC-Specific Over-
activation of the NF-kB Pathway, and Ef-
fects of These Alterations on MC Numbers
In Vivo
(A) Single-cell PCR assay demonstrating efficient
inactivation of the Ikk2 and the Nemo gene in MCs
of Ikk2FL/FLMcpt5-Cre+ and NemoFLMcpt5-Cre+
mice, respectively. Single MCs and non-MCs
(macrophages [Mac] and B and T cells) from
peritoneal cell (PC) or skin cell suspensions were
deposited into PCR tubes by FACS, and the locus
of interest was amplified from each cell by nested
PCR to assess whether the loxP-flanked fragment
was deleted by Cre-mediated recombination or
not. (See Figure S1 for PCR strategy and examples
of PCR results and Table S1 for the entire data set.)
(B) Western blot analysis of IkBa in Ikk2casFL
Mcpt5-Cre+ PCMCs FACS-sorted as CD117+
FcεRIa+eGFP+ cells (representative of four mice).
(C) MCs were quantified in peritoneal lavage fluid
and skin cell suspensions from animals of the
indicated genotypes by flow cytometry. Median
and interquartile ranges are indicated.We intended to investigate the role of IKK complex com-
ponents in MCs and, in particular, IKK2-mediated MC degranu-
lation in various MC in vivo responses. For this purpose, we
employed MC-specific gene targeting using Mcpt5-Cre mice,
which allows the analysis of gene function in MCs in situ. We
generated mouse lines in which we ablated IKK2 or NEMO spe-
cifically in MCs, and mice with MC-specific expression of a
mutant, constitutively active IKK2 protein. Unexpectedly, we
found that degranulation of IKK2-deficient MCs was not
impaired in vitro or in vivo compared to control MCs.
RESULTS
Mice with MC-Specific Inactivation or Overactivation of
the IKK Complex
We recently described efficient Cre-mediated recombination in
connective tissue MCs (CTMCs) in Mcpt5-Cre transgenic mice
(Dudeck et al., 2011; Scholten et al., 2008). In order to inactivate
or to constitutively activate the IKK complex in CTMCs in vivo,
Mcpt5-Cre mice were crossed to Ikk2FL (Pasparakis et al., 2002)
andNemoFLmice (Schmidt-Supprian et al., 2000) or the Ikk2casFL
mouse strain, respectively. The latter mice express a mutant,
constitutively active IKK2 protein (IKK2ca) in cells that excised a
loxP-flanked stop element by Cre-mediated recombination
(Sasaki et al., 2006). Highly efficient and MC-specific inactivationCell Reports 8, 1300–1307, Sepof the Ikk2 and the (X-chromosomal)
Nemo gene in Ikk2FL/FLCre+ mice and
NemoFLCre+ mice (male NemoFL/Y and
female NemoFL/FL), respectively, was
demonstrated by nested single target
amplification of the mutated locus from
single MCs and non-MCs purified by fluo-
rescence-activated cell sorting (FACS)from peritoneal lavage or skin cell suspensions (Figures 1A,
S1A, S1B, S1D, and S1E; Table S1). Absence of IKK2 and
NEMO protein in peritoneal MCs expanded in vitro (PCMCs)
was verified by western blot (Figures S1C and S1F). Cell type
specificity and efficiency of Cre-mediated activation of the
ROSA26 Ikk2casFL knockin allele was determined by monitoring
expressionof theeGFPmarker coexpressedwith IKK2ca (Figures
S1G–S1I). Spontaneous degradation of IkBa was demonstrated
in PCMCs (Figure 1B). Loss of IKK2 or NEMO or expression of
constitutively active IKK2 did not affect numbers (Figure 1C) and
phenotype of MCs in peritoneal lavage or skin except for a slight
reduction of CD117 expression (data not shown).
Complete Loss or Constitutive Gain of IKK2 Activity
or IKK Disruption through NEMO Ablation Specifically
in Mast Cells Do Not Influence IgE-Induced
Anaphylaxis In Vivo
TheMcpt5-Cre transgene is active in CTMCs but not in mucosal
MCs (Dudeck et al., 2011). We first determined the contribution
of CTMCs in the anaphylactic response to intraperitoneally
(i.p.) injected allergen and induced passive systemic anaphylaxis
(PSA) inR-DTA+Mcpt5-Cre+mice. These mice are characterized
by profound CTMC deficiency (Dudeck et al., 2011). Other he-
matopoietic cell types, including basophils, were not altered in
numbers (Figure S2A). Although body temperature (determinedtember 11, 2014 ª2014 The Authors 1301
Figure 2. Neither MC IKK2 nor NEMO Is Required for IgE-Induced Anaphylaxis, and Constitutive Activity of IKK2 Has Little Effect on
Anaphylaxis In Vivo
(A) PSA in R-DTA+Mcpt5-Cre+mice (constitutively MC-deficient, see also Figure S2), Ikk2FL/FLMcpt5-Cre+, NemoFLMcpt5-Cre+, Ikk2casFLMcpt5-Cre+mice, and
the respective Cre-negative littermate controls. Drop of body temperature wasmeasured using a rectal probe. Mock controls were sensitized but received saline
instead of allergen challenge. The slight increase of amplitude and duration of the response of Ikk2casFLMcpt5-Cre+ compared to control mice was not repro-
duced in a second experiment based on infrared temperature monitoring (Figure S2B).
(B) PCA in R-DTA+Mcpt5-Cre+ mice, Ikk2FL/FLMcpt5-Cre+ and NemoFLMcpt5-Cre+ mice, Ikk2casFLMcpt5-Cre+ mice, and the respective Cre-negative controls.
Mock controls were not sensitized but challenged. R-DTA Cremock controls gave results similar to all other genotypes (not shown for graphical clarity). Mean
ear swelling ±SD is displayed. Vascular leak was quantified by measuring OD of Evans blue extracted from ear tissue. PBS-injected ears served as control.
Mean ± SD is displayed in (A) and (B). *p < 0.05, **p < 0.01, ***p < 0.001 (comparison between Cre+ and Cre in A and B).by rectal probe) dropped by 4C in R-DTA+Cre-negative con-
trol mice, no response was detectable in MC-deficient
R-DTA+Mcpt5-Cre+ animals (Figure 2A).1302 Cell Reports 8, 1300–1307, September 11, 2014 ª2014 The AuWe also analyzed R-DTA Mcpt5-Cre+ for their capacity to
mount immediate phase passive cutaneous anaphylaxis (PCA)
responses. Animals were locally sensitized with anti-DNP-IgEthors
by injections into the ear pinna. Following intravenous (i.v.) chal-
lenge with HSA-DNP 24 hr later, wemonitored ear thickness and
vascular leakage (Figure 2B). Allergen-induced ear swelling and
vascular leakage were reduced to control levels in the MC-defi-
cient group. These results showed that CTMCs are the major
effector cells in the PSA response to i.p.-injected allergen as
well as the PCA response to i.v.-injected allergen.
To test whether deletion of IKK2 or NEMO in CTMCs or MC-
specific expression of constitutively active IKK2 affected IgE-
induced in vivo responses, PSA was induced in the mutant
mouse lines. MC-specific loss of IKK2 or NEMO had no effect
on the response to the allergen (Figure 2A). We performed inde-
pendent experiments in which skin temperature was measured
using an infrared camera (Figure S2B) and obtained similar re-
sults. Expression of constitutively active IKK2 in connective tis-
sue MCs resulted in enhanced and prolonged PSA in the first
experiment (Figure 2A), which, however, was not reproduced
in a second experiment based on infrared skin temperature
recording (Figure S2B). Confounding effects of the Mcpt5-Cre
transgene itself were excluded by analysis of Mcpt5-Cre+ mice
devoid of loxP-flanked genes, which behaved indistinguishably
from wild-type mice (Figure S2B). Thus, MC IKK2 and NEMO
are dispensable for systemic anaphylaxis and constitutive IKK2
activity in MCs enhances anaphylaxis only moderately, if at all.
We next investigated the PCA response of mice of the three
mutant lines. The ear swelling response of the MC-specific
IKK2 and NEMOmutant mice was not different from that of con-
trols (Figure 2B). Likewise, allergen-induced extravasation of
Evans blue was not different between mutant and control ani-
mals (Figure 2B). Ikk2casFLMcpt5-Cre+ mice did not show
significantly different responses in ear swelling or Evans blue
extravasation compared to control mice (Figure 2B). Mcpt5-
Cre+ mice without loxP-flanked genes were analyzed to control
for effects of the transgene alone (Figure S2C). Thus, MC-spe-
cific inactivation of the Ikk2 or the Nemo gene does not affect
IgE-mediated anaphylactic responses in vivo. Selective expres-
sion of constitutively active IKK2 in MCs resulted in significantly
enhanced responses in only one of three independent assays
(PSA, PCA, and Evans blue extravasation) and in the PSA assay
only in one of two independent experiments. We therefore
conclude that inhibition or constitutive activation of IKK2 does
not affect anaphylactic responses in vivo.
Loss of IKK2 or NEMO or Constitutive IKK2 Activity Do
Not Affect MC Degranulation or SNARE Protein
Phosphorylation In Vitro
Suzuki and Verma described impaired in vitro degranulation of
MCs differentiated from the fetal liver of Ikk2/ mice and an
essential function of IKK2 in the phosphorylation of SNAP23 (Su-
zuki and Verma, 2008). We triggered degranulation of PCMCs
derived from Ikk2FL/FLMcpt5-Cre+ and NemoFLMcpt5-Cre+
mice. Absence of the respective proteins in these cells was
demonstrated by western blot (Figures S1C and S1F). Degranu-
lation of IKK2-deficient PCMCs and of NEMO-deficient PCMCs
was similar to the response of control cells as determined by
quantification of surface phosphatidylserine. This molecule
translocates to the outer leaflet of the plasma membrane upon
MC degranulation and can be detected by annexin V stainingCell Re(Figures 3A and 3B). Allergen-triggered IKK2-deficient and
NEMO-deficient PCMCs released similar amounts of b-hexosa-
minidase as control cells (Figure 3A). Also, the early release of
TNF, which is stored in the MC granules, is a measure of degran-
ulation (before onset of IgE-induced de novo synthesis of this
cytokine). IKK2- and NEMO-deficient MCs did not differ from
control cells in TNF release 30 min after allergen challenge (Fig-
ure 3C; data not shown). In addition to triggering degranulation
by IgE crosslinking, we treated IKK2- or NEMO-deficient PCMCs
with the calcium ionophore A23187 and observed similar b-hex-
osaminidase release compared to control cells (Figure 3A).
Moreover, we found unimpaired allergen-induced degranulation
of IKK2-deficient bone marrow-derived MCs (BMMCs) (Figures
S3A–S3D). Allergen-induced phosphorylation of SNAP23 on
Ser95 and Ser120 was not affected by IKK2-deficiency as
demonstrated by western blot (Figures 3D, 3E, and S3E).
Expression of constitutively active IKK2 in PCMCs from
Ikk2casFLMcpt5-Cre+ mice did not affect allergen-induced
degranulation (Figure 3A). In summary, we show that IKK2 and
NEMO are dispensable for IgE-induced SNAP23 phosphoryla-
tion and MC degranulation in vitro.
IKK2 and NEMO Are Essential for the MC Late-Phase
Response to Allergen
Hours after IgE crosslinking, MCs de novo synthesize TNF, inter-
leukin 6 (IL-6), pro-IL-1b, and other mediators. In order to test
whether this late-phase response is dependent on IKK complex
components, we sensitizedmice withMC-specific deficiency for
IKK2 or NEMO, or animals with MC-specific expression of
constitutively active IKK2 by i.v. injection of anti-DNP-IgE. The
animals were challenged 24 hr later by epicutaneous administra-
tion of DNFB, and the resulting ear swelling was monitored. The
responsewas severely impaired inmice lacking IKK2 or NEMO in
MCs (Figures 4A, 4B, and S4A). Ikk2casFLMcpt5-Cre+ animals
showed slightly enhanced responses compared to controls;
however, the difference was significant only at one time point
(Figure 4C).
In order to assess IgE-induced de novo expression of proin-
flammatory cytokines, we stimulated IKK2-deficient BMMCs
(Figure S4B), NEMO-deficient PCMCs, and IKK2ca-overex-
pressing BMMCs by FcεRI crosslinking (Figures 4D–4F). The
cytokine responses of IKK2- and NEMO-deficient cells were
significantly reduced as determined by RT-PCR-based quantifi-
cation of mRNAs and by determination of cytokine concentra-
tions in the supernatant. In accordance with the results shown
in Figure 3, the same cultures were not impaired in their degran-
ulation response (Figure S4C; data not shown). In accordance
with the results obtained from IKK2-deficient cells, the cytokine
response of cells overexpressing the constitutively active
IKK2ca protein featured a significantly enhanced cytokine
response (Figure 4F). Thus, IKK2 and NEMO are essential for
normal IgE-induced MC cytokine responses and constitutive
IKK2 activity enhances these responses.
DISCUSSION
FcεRI-induced MC degranulation is a key event in the pathogen-
esis of allergic diseases. Induction of second messengers andports 8, 1300–1307, September 11, 2014 ª2014 The Authors 1303
Figure 3. Deficiency for IKK Complex Components or Expression of Constitutively Active IKK2 Has No Effect on MC Degranulation In Vitro
Peritoneal lavage cells were cultivated in the presence of stem cell factor and IL-3. The cells were loaded overnight with anti-DNP-IgE and then stimulated with
HSA-DNP (‘‘+ DNP’’). Control cell samples were exposed to HSA instead of allergen (‘‘ DNP’’).
(A) Degranulation of PCMCs from Ikk2FL/FLMcpt5-Cre+ as well asNemoFLMcpt5-Cre+ and Ikk2casFLMcpt5-Cre+mice and the respective Cre-negative littermates
(n = 3–7 per group). In two independent experiments, degranulationwas quantified by annexin V staining (upper panel) and by determination of b-hexosaminidase
release (middle panel). The latter experiment included a ‘‘Mcpt5-Cre only’’ group to exclude confounding effects of the transgene itself. Degranulation was also
induced by the ionophor A23187 (lower panel). Means obtained for allergen- or ionophor-treated Cre-negative control cells were set to 100%. Mean ± SD is
shown. *p < 0.001, n.s., not significant. IKK2-deficient BMMCs yielded similar results as obtained for IKK2-deficient PCMCs (see Figure S3).
(B) Example of degranulation of Ikk2FL/FLMcpt5-Cre+ and Ikk2FL/FLCre-negative control PCMCs as determined by flow cytometric quantification of surface an-
nexin V (from the data set represented in A).
(C) TNF release from Ikk2FL/FLMcpt5-Cre+ aswell as Cre-negative and ‘‘Mcpt5-Cre only’’ control PCMCs allergen-stimulated as in (B). Supernatant was harvested
for ELISA 30 min after allergen challenge. Mean ± SD is shown.
(D) Phosphorylation of SNAP23 in PCMCs from one Ikk2FL/FLMcpt5-Cre+ and one Cre-negative control mouse sensitized and triggered as described above was
assessed by phospho-specific western blot analysis. See Figure S3 for results obtained for four additional mutant and five additional control samples.
(E) Quantification of phospho-SNAP23 induction in Ikk2FL/FLMcpt5-Cre+ and control cells by densitometric analysis of all western blot results. Shown are
geometric mean and 95% confidence interval of six values per genotype and stimulation condition.PKC activation by proximal FcεRI signaling has been intensely
studied, whereas coupling of these signals to exocytosis of
MC granules is incompletely understood. Suzuki and Verma re-
ported that IKK2 serves an essential function in MC degranula-
tion by phosphorylating the SNARE protein SNAP23 (Suzuki
and Verma, 2008). We generated mice with selective knockouts
of the Ikk2 or the Nemo gene in MCs and mice with MC-specific
expression of a constitutively active IKK2 protein. Surprisingly,
we found that loss of IKK2 in MCs did not affect their allergen-
induced degranulation. Given the tremendous importance of1304 Cell Reports 8, 1300–1307, September 11, 2014 ª2014 The Aumolecular mechanisms of MC degranulation for human dis-
eases, we decided to use our models to clarify the role of IKK
complex components in MC responses. We confirmed that a
functional IKK complex is required for the IgE-induced MC
late-phase cytokine response. We demonstrate, however, that
IKK2 is dispensable for SNARE protein phosphorylation and for
degranulation in vitro and in vivo.
Suzuki and Verma differentiated MCs from fetal liver of Ikk2/
embryos (E11.5–12.5) to circumvent lethality of this mutation.
These cells were compromised in their degranulation responsethors
Figure 4. The Late-Phase MC Response Is Dependent on a Functional IKK Complex
LP-PCA was induced by i.v. sensitization with anti-DNP-IgE and challenge by epicutaneous administration of DNFB followed by monitoring of ear thickness.
(A) Five Ikk2FL/FLMcpt5-Cre+ and four Cre-negative littermate controls were analyzed. A Cre-negative control animal was sensitized but treated with vehicle
(acetone/olive oil) alone, instead of challenge (Ø challenge). One Ikk2FL/FLMcpt5-Cre+ was not sensitized but challenged with DNFB (Ø sensitization). The latter
two animals served as controls also for data in (B) and (C), which were generated in parallel with data in (A). (See Figure S4 for a second experiment.)
(legend continued on next page)
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to FcεRI crosslinking. Moreover, upon transfer into MC-deficient
WBB6F1-KitW/KitWv mice, wild-type but not Ikk2/ FLMCs re-
paired defective anaphylaxis of the recipients. An important dif-
ference between the experimental models used is that the entire
MCdifferentiation from Ikk2/ fetal-liver-derivedprecursors pro-
ceeds in the absence of IKK2. In contrast, Ikk2FL/FLMcpt5-Cre+
mice represent normal animals in which MCs differentiate in the
presence of IKK2. Only during the last steps of MC maturation,
the Mcpt5 promoter is activated resulting in Cre-mediated inac-
tivation of the Ikk2 gene. We hypothesize that IKK2 may serve
an important function in earlier steps of MC differentiation (occur-
ring before induction of the Mcpt5-promoter), loss of which re-
sults in defective MCs characterized by impaired degranulation.
We show that phosphorylation of SNAP23 on Ser95 and
Ser120 is not compromised in IKK2-deficient PCMCs. In MCs
differentiated under physiological conditions, i.e., in the pres-
ence of IKK2, SNAP23 phosphorylation induced by FcεRI activa-
tion may depend on kinases other than IKK2 or may represent a
redundant function of different kinases, including IKK2. MCs
lacking IKK2 throughout differentiation from fetal liver cells may
be deficient in these pathways. An argument against this con-
cept is that we found normal degranulation in BMMCs differenti-
ated from IKK2-deficient bonemarrow cells. Also, these BMMCs
lacked IKK2 throughout their development but were not compro-
mised in granule exocytosis. However, abnormal differentiation
may be a distinctive feature of MCs differentiated in vitro from
fetal liver cells.
Local responses of skin MCs were not changed in mice with
MC-specific loss of IKK2, and in vitro degranulation of IKK2-defi-
cient MCs was not different from the response of control cells.
Constitutive IKK2 activity in MCs slightly enhanced systemic
anaphylaxis in one experiment. This, however, was not repro-
duced in a second experiment. Therefore, our experiments
demonstrate that even overexpression of a constitutively active
IKK2 has only a minor, if any, impact on MC degranulation.
Collectively, our results rule out an essential role for IKK2 in the
signal transduction events leading to MC degranulation.
In conclusion, the question of how FcεRI-triggered second
messenger signals are coupled to MC secretory granule exocy-
tosis remains open. The identification of kinases responsible for
allergen-induced SNARE-protein phosphorylation remains an
important task because they might represent a target for thera-
peutic suppression of the MC response in allergic diseases.
EXPERIMENTAL PROCEDURES
Mice
Mcpt5-Cre (Scholten et al., 2008), Mx-Cre (Ku¨hn et al., 1995), R-DTA (Voeh-
ringer et al., 2008), R26StopFLIkk2ca (Ikk2casFL; Sasaki et al., 2006), Ikk2FL(B) LP-PCA in ten male NemoFL/YMcpt5-Cre+, six Cre-negative controls (five male
female NemoFL/WTMcpt5-Cre+ control mice.
(C) LP-PCA in six Ikk2casFLMcpt5-Cre+ and seven Cre controls.
(D–F) (D) BMMCs from poly I:C-induced Ikk2FL/FLMx-Cre+ mice, or (E) PCM
Ikk2casFLMx-Cre+ mice and the respective Cre-negative littermate controls wer
mRNA levels were assessed 1 hr after antigen challenge by quantitative RT-PCR
compared to HSA-exposed Cre-negative control cells are displayed.
All samples were assayed in triplicates. Concentrations of TNF and IL-6 in the cultu
SD is displayed. *p < 0.05, **p < 0.01, ***p < 0.001; n.s., not significant.
1306 Cell Reports 8, 1300–1307, September 11, 2014 ª2014 The Au(Pasparakis et al., 2002), and NemoFL mice (Schmidt-Supprian et al., 2000),
all C57BL/6, were bred and housed at the Experimental Center, Medical Fac-
ulty Carl-Gustav Carus, TU Dresden, under specific pathogen-free conditions.
In all experiments, littermates were used as controls. All animal experimenta-
tion was performed according to institutional guidelines and was approved by
the Landesdirektion Dresden.
Passive Systemic Anaphylaxis
Mice were sensitized by i.p. injection of 12.5 mg SPE-7 anti-DNP-IgE (Eshhar
et al., 1980). Twenty-four hours later, mice were challenged by i.p. injection
of 200 mg human serum albumin (HSA)-DNP (Sigma-Aldrich) in 0.9% NaCl or
NaCl alone. Temperature drop was assessed using a rectal thermometer
(Bio-TK 9882, Bioseb).
Passive Cutaneous Anaphylaxis
Mice were locally sensitized by intradermal injection of 20 ng anti-DNP-IgE
(Sigma-Aldrich) in 20 ml PBS into the left ear pinna. Twenty-four hours later,
mice were challenged by i.v. injection of 100 mg HSA-DNP (Sigma-Aldrich) in
0.9%NaCl. Ear thickness wasmonitored thereafter using an engineer’smicro-
meter (Mitutoyo). Ear swelling was determined as percentage increase
compared to prechallenge ear thickness. Additional mice were sensitized on
the left ear as described above but also received an injection of 20 ml PBS
into the right ear. The next day, mice were challenged with 100 mg HSA-DNP
in 140 ml 2% Evans blue. After 30 min, mice were sacrificed, and ear tissue
was incubated in 500 ml formamide at 50C for 4–5 days. Extracted dye was
quantified photometrically at 620 nm.
For quantification of the late-phase anaphylactic response, mice were
sensitized by i.v. injection of 5 mg SPE-7 anti-DNP-IgE on 2 consecutive
days. On day 3, mice were challenged by epicutaneous administration of
10 ml 0.2% (w/v) DNFB (Sigma-Aldrich) in acetone/olive oil (4:1) onto both sides
of the ear. Ear thickness was measured before and 12, 24, and 48 hr after
challenge.
Induction and Quantification of MC Degranulation
PCMCs were incubated with 1 mg/ml SPE-7 anti-DNP-IgE and stimulated
with 100 ng/ml HSA-DNP or HSA alone. In some experiments, cells were
left unsensitized and were stimulated with 500 ng/ml A23187 (Sigma-
Aldrich) for 30 min. b-hexosaminidase release was determined as per-
centage release of total content (percentage release = 100 3 amount
supernatant/ (amount in supernatant + cell lysate)). To quantify surface
phosphatidylserin, cells were stained with FITC- or Pacific blue-annexin V
(BioLegend) and propidium iodide. See the Supplemental Experimental Pro-
cedures for details.
Real-Time RT-PCR
RNA was reverse transcribed by Revert Aid HMinus RT (Thermo Fisher Scien-
tific). Specific mRNAs were quantified using SYBR Green/ROX qPCR Master
Mix (Thermo Fisher Scientific), and the primers are listed in the Supplemental
Experimental Procedures.
ELISA
TNF and IL-6 protein levels in supernatants of stimulated PCMC or BMMC cul-
tures were determined by ELISA (eBiosciences) as recommended by the man-
ufacturer’s protocol.NemoFL/Y, one female NemoFL/FL, collectively addressed as NemoFL) and four
Cs from NemoFLMcpt5-Cre+ mice, or (F) BMMCs from poly I:C-induced
e sensitized and allergen-stimulated as described above (Figure 3). Cytokine
. Ct values were normalized to TBP and relative changes in transcript levels
re supernatant were determined 6 hr after antigen challenge by ELISA. Mean ±
thors
Statistical Analysis
Data are shown asmeans ± SD if not stated otherwise. Statistical analysis was
performed using Student’s t test or two-way ANOVA. Significance levels are
indicated in each figure.
SUPPLEMENTAL INFORMATION
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